Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies. (Q37230848)
Jump to navigation
Jump to search
scientific article published on January 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies. |
scientific article published on January 2009 |
Statements
Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies (English)
Alison C MacKinnon
Uzma Tufail-Hanif
Adriano G Rossi
Christopher Haslett
Michael Seckl
1 January 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference